Literature DB >> 18425045

Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection.

Lorenzo Cerroni1, Cesare Massone, Heinz Kutzner, Thomas Mentzel, Pablo Umbert, Helmut Kerl.   

Abstract

Most cases of intravascular large cell lymphoma have a B-cell phenotype, but rare T-cell and natural killer (NK)-cell variants have been reported. We describe the clinicopathologic features of 4 patients (M:F=3:1; age range: 63 to 87; median age: 65) with intravascular large NK/T-cell lymphoma. The skin was the site of presentation in all patients (leg: 1 case; trunk: 1 case; trunk and extremities: 2 cases). Two patients had lesions confined to the skin; in 1 case concomitant involvement of the brain was detected and in 1 case no further studies were carried out. Immunohistology showed positivity for cytotoxic markers in 3/4 cases. One case had an NK phenotype similar to NK/T-cell lymphoma, nasal-type, whereas the other cases could not be precisely classified into specific categories (peripheral T-cell lymphoma, NOS). One of these cases was negative for cytotoxic markers and was positive only for CD2 and CD3 epsilon. Association with Epstein-Barr virus (EBV) was demonstrated in 2 cases by in situ hybridization, whereas 1 case was negative. All our patients had aggressive disease and died between 2 weeks and 7 months from presentation. Analysis of our cases and of those published in the literature shows that intravascular large NK/T-cell lymphoma is a rare, aggressive lymphoma with variable phenotypic features, frequent expression of cytotoxic proteins, true NK-cell phenotype and association with Epstein-Barr virus infection, and common presentation in the skin. Homogeneous studies on larger number of patients and reevaluation of cases published with incomplete phenotypic data would be necessary to gather more information on this extremely rare type of lymphoma.

Entities:  

Mesh:

Year:  2008        PMID: 18425045     DOI: 10.1097/PAS.0b013e31815d29c9

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

Review 1.  [Clinical and pathological characteristics of intravascular lymphomas].

Authors:  L Abraham; H Kreipe; P Raab; K Hussein
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

2.  Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.

Authors:  Genevieve M Crane; Rena R Xian; Kathleen H Burns; Michael J Borowitz; Amy S Duffield; Janis M Taube
Journal:  J Cutan Pathol       Date:  2014-12-08       Impact factor: 1.587

Review 3.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

4.  HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma.

Authors:  Genevieve M Crane; Richard F Ambinder; Courtney M Shirley; Elliot K Fishman; Yvette L Kasamon; Janis M Taube; Michael J Borowitz; Amy S Duffield
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

5.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

6.  Traumatic ulcerative granuloma with stromal eosinophilia of the palate showing an angiocentric/angiodestructive growth pattern.

Authors:  Bernardo Ferreira Brasileiro; Daniel Berretta Alves; Bruno Augusto Benevenuto Andrade; Pablo Agustin Vargas; Jorge Esquiche León; Oslei Paes De Almeida
Journal:  Contemp Clin Dent       Date:  2012-04

7.  Asian-variant intravascular lymphoma in the African race.

Authors:  Holly Geyer; Nina Karlin; Brian Palen; Ruben Mesa
Journal:  Rare Tumors       Date:  2012-03-19

Review 8.  Intravascular NK-cell lymphoma: a case report and review of the literature.

Authors:  Yalan Bi; Zhen Huo; Zhiyong Liang; Yunxiao Meng; Congwei Jia; Xiaohua Shi; Lan Song; Yufeng Luo; Qing Ling; Tonghua Liu
Journal:  Diagn Pathol       Date:  2015-07-01       Impact factor: 2.644

Review 9.  Cutaneous Intravascular NK/T-cell lymphoma mimic panniculitis clinically, case report and literature brief review.

Authors:  Ahmed Alhumidi
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

10.  Intravascular cytotoxic T-cell lymphoma in a young immunocompetent woman.

Authors:  Yong Hyun Jang; Seok-Jong Lee; Yoon Hyuk Choi; Weon Ju Lee; Do Won Kim; Jeongshik Kim; Tae In Park; Yee Soo Chae
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.